Liver Injury/Regeneration

You have full text access to this OnlineOpen article

Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: Heparin prevents and treats liver damage ^†

Sujith V. W. Weerasinghe¹,
David S. Moons²,
Peter J. Altshuler¹,
Yatrik M. Shah^1,3,
M. Bishr Omary^1,3,‡,*

Article first published online: 7 APR 2011

DOI: 10.1002/hep.24203

Issue

Hepatology

Volume 53, Issue 4, pages 1323–1332, April 2011

Additional Information

How to Cite

Weerasinghe, S. V. W., Moons, D. S., Altshuler, P. J., Shah, Y. M. and Omary, M. B. (2011), Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: Heparin prevents and treats liver damage . Hepatology, 53: 1323–1332. doi: 10.1002/hep.24203

Author Information

¹
Molecular & Integrative Physiology, University of Michigan Medical School, 1137 Catherine Street, 7744 Med Sci II, Ann Arbor, MI 48109
²
Pathology, University of Michigan Medical School, 1137 Catherine Street, 7744 Med Sci II, Ann Arbor, MI 48109
³
Medicine, University of Michigan Medical School, 1137 Catherine Street, 7744 Med Sci II, Ann Arbor, MI 48109

^‡
fax: 734-936-8813.

^*University of Michigan Medical School, Department of Molecular & Integrative Physiology, 7744 Medical Science Building II, 1137 Catherine Street, Ann Arbor, MI 48109-5622

^†
Potential conflict of interest: Nothing to report.
^‡
fax: 734-936-8813.

Publication History

Issue published online: 7 APR 2011
Article first published online: 7 APR 2011
Accepted manuscript online: 27 JAN 2011 05:04AM EST
Manuscript Accepted: 9 JAN 2011
Manuscript Received: 26 AUG 2010

Funded by

National Institutes of Health. Grant Number: DK47918
Department of Veterans Affairs

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (1825K)

References

1
Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? HEPATOLOGY 2006; 43: S31-S44.
Direct Link:
2
Malhi H, Guicciardi ME, Gores JG. Hepatocyte death: a clear and present danger. Physiol Rev 2010; 90: 1165-1194.
3
Ku NO, Liao J, Omary MB. Apoptosis generates stable fragments of human type I keratins. J Biol Chem 1997; 272: 33197-33203.
4
Caulin C, Salvesen GS, Oshima RG. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 1997; 138: 1379-1394.
5
Rao L, Perez D, White E. Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 1996; 135: 1441-1455.
6
Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nat Med 1997; 3: 409-413.
7
Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182: 1223-1230.
8
Guicciardi ME. Apoptosis: a mechanism of acute and chronic liver injury. Gut 2005; 54: 1024-1033.
9
Lisman T, Porte RJ. Activation and regulation of hemostasis in acute liver failure and acute pancreatitis. Semin Thromb Hemost 2010; 36: 437-443.
10
Mosesson MW, Homandberg GA, Amrani DL. Human platelet fibrinogen gamma chain structure. Blood 1984; 63: 990-995.
11
Drury DR, McMaster PD. The liver as a source of fibrinogen. J Exp Med 1929; 50: 569.
- CrossRef,
- PubMed,
- CAS
12
Mosesson MW. Fibrinogen gamma chain functions. J Thromb Haemost 2003; 1: 231-238.
Direct Link:
13
Farrel DH. Pathophysiologic roles of the fibrinogen gamma chain. Curr Opin Hematol 2004; 11: 151-155.
14
Chen R, Doolittle RF. Cross-linking sites in human and bovine fibrin. Biochemistry 1971; 10: 4487-4491.
15
Vejda S, Posovszky C, Zelzer S, Peter B, Bayer E, Gelbmann D, et al. Plasma from cancer patients featuring a characteristic protein composition mediates protection against apoptosis. Mol Cell Proteomics 2002; 1: 387-393.
16
Gerner C, Steinkellner W, Holzmann K, Gsur A, Grimm R, Ensinger C, et al. Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis. Thromb Haemost 2001; 85: 494-501.
17
Fujiwara K, Ogata I, Ohta Y, Hirata K, Oka Y, Yamada S, et al. Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III. Gut 1988; 29: 1103-1108.
18
Ganey PE, Luyendyk JP, Newport SW, Eagle TM, Maddox JF, Mackman N, et al. Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice HEPATOLOGY 2007; 46: 1177-1186.
Direct Link:
19
Rake MO, Flute PT, Shilkin KB, Lewis ML, Winch J, Williams R. Early and intensive therapy of intravascular coagulation in acute liver failure. Lancet 1971; 2: 1215-1218.
20
Ku NO, Toivola DM, Zhou Q, Tao GZ, Zhong B, Omary MB. Studying simple epithelial keratins in cells and tissues. Methods Cell Biol 2004; 78: 489-517.
21
Tao GZ, Li DH, Zhou Q, Toivola DM, Strnad P, Sandesara N, et al. Monitoring of epithelial cell caspase activation via detection of durable keratin fragment formation. J Pathol 2008; 215: 164-174.
Direct Link:
22
Siebenlis KR, Mosesson MW. Progressive cross-linking of fibrin γ chains increases resistance to fibrinolysis. J Biol Chem 1994; 269: 28414-28419.
- PubMed,
- Web of Science® Times Cited: 38
23
Lee WM. Etiologies of acute liver failure. Semin Liver Dis 2008; 28: 142-152.
24
Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010; 376: 190-201.
25
Tennent GA, Brennan SO, Stangou AJ, O'Grady J, Hawkins PN, Pepys MB. Human plasma fibrinogen is synthesized in the liver. Blood 2007; 109: 1971-1974.
26
Pathikonda M, Munoz SJ. Acute liver failure. Ann Hepatol 2010; 9: 7-14.
- PubMed,
- Web of Science®
27
Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137: 856-864.
28
Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 1996; 16: 403-414.
29
Munoz SJ, Stravitz RT, Gabriel DA. Coagulopathy of acute liver failure. Clin Liver Dis 2009; 13: 95-107.
30
Pernambuco JR, Langley PG, Hughes RD, Izumi S, Williams R. Activation of the fibrinolytic system in patients with fulminant liver failure. HEPATOLOGY 1993; 18: 1350-1356.
Direct Link:
31
Massicotte L, Beaulieu D, Thibeault L, Roy JD, Marleau D, Lapointe R, et al. Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation 2008; 85: 956-962.
32
Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22: 659-661.
33
Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 188S-203S.

View Full Article with Supporting Information (HTML) Get PDF (1825K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: Heparin prevents and treats liver damage ^†

Hepatology

How to Cite

Author Information

Publication History

Funded by

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: Heparin prevents and treats liver damage †

Hepatology

How to Cite

Author Information

Publication History

Funded by

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this

Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: Heparin prevents and treats liver damage ^†